A Glucose Oxidase-Curcumin Composite Nanoreactor for Multimodal Synergistic Cancer Therapy
ACS Applied Bio Materials · 15.07.2024 · 7 (7) · 4611-4621
DOI: 10.1021/acsabm.4c00479 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 26.06.2024. Verfasst von Rama Alsamarat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan. Hauptthemen laut MEDLINE: Curcumin, Glucose Oxidase, Antineoplastic Agents, Particle Size. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: International Centre for Genetic Engineering and Biotechnology, Al-Zaytoonah University of Jordan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.
ORCID-Profile: Suhair Sunoqrot
Förderung
- International Centre for Genetic Engineering and Biotechnology
- Al-Zaytoonah University of Jordan
Zitieren
APA
Alsamarat, R., & Sunoqrot, S. (2024). A Glucose Oxidase-Curcumin Composite Nanoreactor for Multimodal Synergistic Cancer Therapy. ACS Applied Bio Materials, 7(7), 4611-4621. https://doi.org/10.1021/acsabm.4c00479
Vancouver
Alsamarat R, Sunoqrot S. A Glucose Oxidase-Curcumin Composite Nanoreactor for Multimodal Synergistic Cancer Therapy. ACS Applied Bio Materials. 2024;7(7):4611-4621. doi:10.1021/acsabm.4c00479
BibTeX
@article{Alsamarat2024,
author = {Alsamarat, Rama and Sunoqrot, Suhair},
title = {A Glucose Oxidase-Curcumin Composite Nanoreactor for Multimodal Synergistic Cancer Therapy},
journal = {ACS Applied Bio Materials},
year = {2024},
volume = {7},
number = {7},
pages = {4611--4621},
doi = {10.1021/acsabm.4c00479}
}
EUVIMED